According to Gilead Sciences's latest financial reports the company's current revenue (TTM) is $27.13 B. In 2021 the company made a revenue of $27.30 B an increase over the years 2020 revenue that were of $24.68 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2022 (TTM) | $27.13 B | -0.62% |
2021 | $27.30 B | 10.6% |
2020 | $24.68 B | 9.98% |
2019 | $22.44 B | 1.46% |
2018 | $22.12 B | -15.24% |
2017 | $26.10 B | -14.09% |
2016 | $30.39 B | -6.89% |
2015 | $32.63 B | 31.13% |
2014 | $24.89 B | 122.2% |
2013 | $11.20 B | 15.45% |
2012 | $9.70 B | 15.71% |
2011 | $8.38 B | 5.48% |
2010 | $7.94 B | 13.38% |
2009 | $7.01 B | 31.4% |
2008 | $5.33 B | 26.14% |
2007 | $4.23 B | 39.78% |
2006 | $3.02 B | 49.19% |
2005 | $2.02 B | 53.13% |
2004 | $1.32 B | 52.63% |
2003 | $0.86 B | 85.92% |
2002 | $0.46 B | 99.68% |
2001 | $0.23 B |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
![]() Johnson & Johnson JNJ | $94.94 B | 249.88% | ๐บ๐ธ USA |
![]() Pfizer PFE | $99.67 B | 267.32% | ๐บ๐ธ USA |
![]() AbbVie ABBV | $57.81 B | 113.07% | ๐บ๐ธ USA |
![]() Eli Lilly LLY | $29.23 B | 7.75% | ๐บ๐ธ USA |
![]() Amgen AMGN | $26.33 B | -2.97% | ๐บ๐ธ USA |
![]() Biogen BIIB | $10.36 B | -61.81% | ๐บ๐ธ USA |
![]() Illumina ILMN | $4.69 B | -82.68% | ๐บ๐ธ USA |
![]() Vertex Pharmaceuticals VRTX | $8.70 B | -67.94% | ๐บ๐ธ USA |
![]() Merck MRK | $58.97 B | 117.33% | ๐บ๐ธ USA |